Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2019

SELL
$17.44 - $21.53 $55.8 Million - $68.9 Million
-3,199,176 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$19.97 - $21.96 $3.54 Million - $3.89 Million
177,275 Added 5.87%
3,199,176 $68.4 Million
Q2 2018

Jul 27, 2018

BUY
$20.16 - $24.68 $2.98 Million - $3.65 Million
147,715 Added 5.14%
3,021,901 $65 Million
Q1 2018

May 09, 2018

SELL
$20.31 - $24.95 $563,602 - $692,362
-27,750 Reduced 0.96%
2,874,186 $60.9 Million
Q4 2017

Jan 26, 2018

BUY
$20.99 - $23.89 $1.52 Million - $1.73 Million
72,375 Added 2.56%
2,901,936 $66.5 Million
Q3 2017

Oct 24, 2017

BUY
$20.07 - $21.89 $56.8 Million - $61.9 Million
2,829,561
2,829,561 $61.9 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.89B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.